STACY CLEMMONS: Open Payments
NPI 1801533054 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,440 in 61 payments from 18 companies in 2025. Trend: 2023 $1,297 · 2024 $1,192 · 2025 $1,440
Food & beverage: $1,440
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $453 |
| GlaxoSmithKline, LLC. | 21 | $338 |
| Lilly USA, LLC | 1 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
| GENZYME CORPORATION | 2 | $60 |
| Verona Pharma, Inc. | 3 | $59 |
| Baxter Healthcare | 3 | $54 |
| Philips North America LLC | 2 | $51 |
| Insmed, Inc. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $32 |
Products named: NUCALA, BREZTRI, TRELEGY ELLIPTA, FASENRA, ZEPBOUND, TEZSPIRE, DUPIXENT, Ohtuvayre.
Industry payments across FL — which companies pay providers there.
